The Clinical Activity And Safety Of Anlotinib Combined With Anti-Pd-1 Antibodies In Patients With Advanced Solid Tumors.Min Yuan,Juemin Fang,Zhongzheng Zhu,Wei Mao,Hui Wang,Weixing Liu,Hong Qian,Jianguo Wu,Xianling Guo,Qing XuJOURNAL OF CLINICAL ONCOLOGY(2020)引用 1|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要